French Public Familiarity and Attitudes toward Clinical Research during the Covid-19 Pandemic

Datos Bibliográficos

ID15464237
AutoresEmily Schultz (0000-0002-6215-3606, Inserm, autor de correspondencia), Jeremy K Ward (0000-0003-3389-6870, Centre National de la Recherche Scientifique), L Atlani-Duault (0000-0002-8529-1788, Université Paris Cité), M Holme (0000-0002-2244-2868, Inserm), Jason Mancini (0000-0001-9500-8598, Inserm)
Año2021
Volumen18
Número5
Páginas2611-2611
Fecha de publicación2021-03-05
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaInternational Journal of Environmental Research and Public Health (JOURNAL)
Identificadores de la revistaISSN: 1661-7827 • E-ISSN: 1660-4601
EditorialMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/ijerph18052611
PMID33807787
OpenAlexW3135532508
IdiomaEN
Citas recibidas2
Referencias citadas42

The COVID-19 pandemic put clinical research in the media spotlight globally. This article proposes a first measure of familiarity with and attitude toward clinical research in France. Drawing from the "Health Literacy Survey 2019" (HLS19) conducted online between 27 May and 5 June 2020 on a sample of the French adult population (N = 1003), we show that a significant proportion of the French population claimed some familiarity with clinical trials (64.8%) and had positive attitudes (72%) toward them. One of the important findings of this study is that positive attitudes toward clinical research exist side by side with a strong distancing from the pharmaceutical industry. While respondents acknowledged that the pharmaceutical industry plays an important role in clinical research (68.3%), only one-quarter indicated that they trust the industry (25.7%). Positive attitudes toward clinical trials were associated with familiarity with clinical trials (Odds Ratio, OR 2.97 [1.90-4.63]), financial difficulties (OR 0.63 [0.46-0.85]), as well as mistrust of doctors (0.48 [0.27-0.85]) and of scientists (OR 0.62 [0.38-0.99]). Although the French media provided a great deal of information on how clinical research works during the first months of the pandemic, there remains profound mistrust of the pharmaceutical industry in France. This suspicion can undermine crisis management, especially in the areas of vaccine development and preparation for future pandemics

Clinical trial · Coronavirus disease 2019 (COVID-19 · Distancing · Environmental health · Family medicine · Geography · Health care · Health literacy · Literacy · Pandemic · Pathology · Pharmaceutical industry · Political science · Population · Public health · Public relations · Quarter (Canadian coin · Ethics in Clinical Research · Medicine · Nursing · Pharmaceutical industry and healthcare · Psychology · Vaccine Coverage and Hesitancy · Pharmacology